Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM Gains 7%; BSE HEALTHCARE Index Up 0.2%
Wed, 30 Oct 12:58

NGL FINE CHM Gains 7%; BSE HEALTHCARE Index Up 0.2%Image source: Eoneren/www.istockphoto.com

NGL FINE CHM share price has zoomed 7% and is presently trading at Rs 1,976.7.

Meanwhile, the BSE HEALTHCARE index is at 43,277.9 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 6.9%) and Natco Pharma (up 3.5%).

Cipla (down 3.6%) and Torrent Pharma (down 2.3%) are among the top losers today.

Over the last one year, NGL FINE CHM has moved up from Rs 1,795.9 to Rs 1,976.7, registering a gain of Rs 180.9 (up 10.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,385.2 to 43,277.9, registering a gain of 58.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 189.8%), SUVEN PHARMACEUTICALS (up 125.0%) and Glenmark Pharma (up 124.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,279.6 (down 0.1%).

The top losers among the BSE Sensex today are ICICI Bank (down 1.7%) and Infosys (down 1.3%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 24,449.9 (down 0.1%). Cipla and Dr. Reddys are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,112.7 to 80,279.6, registering a gain of 16,166.9 points (up 25.2%).

NGL FINE CHM Financial Update...

NGL FINE CHM net profit grew 8.4% YoY to Rs 92 million for the quarter ended June 2024, compared to a profit of Rs 85 million a year ago. Net sales rose 27.7% to Rs 908 million during the period as against Rs 710 million in April-June 2023.

For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.

The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 29.0.


Equitymaster requests your view! Post a comment on "NGL FINE CHM Gains 7%; BSE HEALTHCARE Index Up 0.2%". Click here!